Elizabeth Yeu Lin, Chief Medical Officer: Tarsus Pharmaceuticals TARS Planned sale · Filed 25/12/16

Trade details

Type: Planned sale notice
Stock: Tarsus Pharmaceuticals TARS
Person: Elizabeth Yeu LinChief Medical Officer
Planned sale date: 25/12/16
Filed: 25/12/16

$165.2K to be sold

Tarsus Pharmaceuticals trades, last 26 weeks

What else happened in Tarsus Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/11/16~01/15

Elizabeth Yeu Lin's recent trades

Elizabeth Yeu LinChief Medical Officer
Planned sale10b5-1 planTarsus Pharmaceuticals
Planned sale10b5-1 plan
Tarsus Pharmaceuticals
TARS
$278.3K
3,180 sh
$278.3K
Filed 09/04
Traded 09/04
Elizabeth Yeu LinChief Medical Officer
Planned sale10b5-1 planTarsus Pharmaceuticals
Planned sale10b5-1 plan
Tarsus Pharmaceuticals
TARS
$942.6K
10,773 sh
$942.6K
Filed 09/04
Traded 09/04
Elizabeth Yeu LinChief Medical Officer
Planned sale10b5-1 planTarsus Pharmaceuticals
Planned sale10b5-1 plan
Tarsus Pharmaceuticals
TARS
$127.2K
1,590 sh
$127.2K
Filed 09/02
Traded 09/02
Elizabeth Yeu LinChief Medical Officer
Planned sale10b5-1 planTarsus Pharmaceuticals
Planned sale10b5-1 plan
Tarsus Pharmaceuticals
TARS
$431K
5,387 sh
$431K
Filed 09/02
Traded 09/02
Elizabeth Yeu LinChief Medical Officer
Planned sale10b5-1 planTarsus Pharmaceuticals
Planned sale10b5-1 plan
Tarsus Pharmaceuticals
TARS
$339.8K
4,601 sh
$339.8K
Filed 09/01
Traded 09/01

Elizabeth Yeu Lin, Chief Officer — plans to sell 2,078 sh of Tarsus Pharmaceuticals TARS · $165.2K · around 12/16 | Whalegun